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Abstract 
Background: l-glutathione (GSH) is a non-protein thiol compound with important biological properties and is 
widely used in pharmaceutical, food, cosmetic and health products. The cellular GSH is determined by the activity and 
characteristic of GSH-synthesizing enzymes, energy and precursor supply, and degradation of formed GSH.
Results: In this study, genes encoding enzymes related to the precursor amino acid degradation and glycogen 
formation as well as GSH degradation were systematically manipulated in Escherichia coli strains over-expressing gshF 
from Actinobacillus succinogenes. The manipulation included disrupting the precursor degradation pathways (tnaA 
and sdaA), eliminating l-glutathione degradation (ggt and pepT), and manipulating the intracellular ATP level (disrup-
tion of glgB). However the constructed mutants showed lower levels of GshF expression. 2-D electrophoresis was per-
formed to elucidate the reasons for this discrepancy, and the results indicated obvious changes in central metabolism 
and amino acid metabolism in the penta-mutant. Fed-batch culture of the penta-mutant ZJ12345 was performed 
where the GshF expression level was enhanced, and both the GSH production (19.10 mM) and the yield based on 
added l-cysteine (0.76 mmol/mmol) were significantly increased.
Conclusion: By interrupting the degradation pathways of l-cysteine, serine and GSH and blocking glycogen forma-
tion, the GSH production efficiency was significantly improved.
Keywords: Escherichia coli, Glutathione, Systematic manipulation, Bifunctional glutathione synthetase, Fed-batch 
fermentation
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Background
l-glutathione (γ-glutamyl-l-cysteinylglycine, GSH) is a 
tripeptide that is the most abundant non-protein thiol 
in animals, plants, and microorganisms [1]. Owing to its 
important physiological properties e.g., as an antioxidant 
and detoxifier [2–4], GSH has been widely used in health 
foods, pharmaceuticals, and cosmetics industries [5]. In 
recent years, the commercial demand for glutathione has 
shown a generally increasing trend.
GSH can be synthesized in different microorgan-
isms; however, the yield and productivity are usually 
quite low. Therefore, strain development and bioprocess 
optimization are consequently required for the improve-
ment of GSH biosynthesis. GSH biosynthesis is gen-
erally performed by two consecutive ATP-consuming 
reactions catalyzed by γ-glutamylcysteine synthetase 
(γ-GCS, GSHI) and glutathione synthetase (GS, GSHII) 
from three precursors in microorganisms: l-glutamate, 
l-cysteine, and glycine [1]. Combining the over-expres-
sion of endogenous or exogenous γ-GCS and GS can 
effectively increase GSH synthesis [6]. However, the 
inhibition of γ-GCS activity by GSH is of physiologi-
cal significance [7] and is the rate-limiting step in GSH 
biosynthesis. These features greatly limit GSH accumu-
lation. A great deal of effort has been focused on releas-
ing the feedback inhibition caused by GSH. Murata and 
Kimura [8] screened an E. coli mutant in which GSH I 
was desensitized to feedback inhibition by GSH. When 
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the desensitized GSH I-encoding gene gshA* was cloned, 
the activity of the mutant GSH I increased tenfold com-
pared with the wild type enzyme. Additionally, the intra-
cellular GSH concentration of the strain carrying the 
mutant GSH I was 1.3-fold higher than that of the control 
[8]. The method of two-stage reaction was also adopted 
to release the feedback inhibition of GSH I caused by 
glutathione, and under the optimized condition, com-
mercially available baker’s yeast produced 3.44  g/L of 
glutathione in 30 h [9]. A novel enzyme (the bifunctional 
glutathione synthetase encoded by gshF) that possessed 
both γ-GCS and GS activities and was non-sensitive to 
GSH was discovered in several microorganisms, includ-
ing Streptococcus agalactiae [10], Enterococcus faecalis 
[10], Listeria monocytogenes [11], and Streptococcus ther-
mophiles [12]. The concentration of GSH produced by E. 
coli over-expressing gshF from S. thermophiles reached 
11.1 g/L [12].
Since GSH synthesis contained two ATP-consuming 
reactions, the supplement of ATP became one of the 
major factors which affected the GSH production. The 
glycolytic pathway of Saccharomyces cerevisiae was con-
sidered to be the intracellular ATP regeneration system 
for GSH synthesis [13]. A coupled system composed of 
recombinant E. coli and S. cerevisiae was also used to 
produce GSH [14]. While the efficiency of ATP utilization 
was still low compared to the single yeast system. Yoshida 
et al. [15] reported the enzymatic GSH production using 
metabolic engineered S. cerevisiae which disrupted the 
ATP consuming glucose-glycogen bypass pathway. The 
mutant achieved 3.1-fold higher ATP-generating activity 
and 1.7-fold higher GSH productivity compared with the 
control strain.
With the development of genetic engineering, some 
genetic modification was conducted on the host for a 
higher production. The previous studies were focus on 
improving the activity of the GSH biosynthesis system 
itself [16]. However the degradation of GSH is a crucial 
reason for the low efficiency of GSH production and this 
greatly inhibits the commercial of GSH. Lin et  al. [17] 
reported the key enzymes responding to GSH degrada-
tion in E. coli with the purpose of improving GSH pro-
duction. The results suggest the γ-glutamyltranspeptidase 
(GGT) and tripeptidase (PepT) were the key enzymes of 
GSH degradation and finally there has no degradation 
was observed in the GSH synthesis by the mutant, which 
is disrupted pepT and cultured at 30 °C for 3 h and 42 °C 
for 5 h.
Pathways for the biosynthesis of secondary metabolites 
use precursors synthesizes during glycolysis, the tricar-
boxylic acid cycle and the pentose-phosphate pathway 
[18]. Supply of these precursors might become one of 
the bottlenecks of the secondary metabolite biosynthesis. 
The precursors of GSH synthesis are come from the cen-
tral metabolic pathway and increase the efficiency of pre-
cursors can be another way to increase the production. 
However there has no report about increase the GSH 
production by modification of the precursor pathway. 
In addition, the GSH yield based on l-cysteine is critical 
for the industrial GSH production due to the high price 
of l-cysteine. There has many researches about increas-
ing the production of l-cysteine, such as reduced the 
degradation of l-cysteine by disrupting the l-cysteine 
degradation genes [19] or overexpressed the l-cysteine 
synthetases to increase the l-cysteine concentration [20, 
21]. In this work, the l-cysteine degradation gene was 
disrupted to investigate its effects on GSH synthesis.
Recently, a newly founded bifunctional enzyme GshF 
from Actinobacillus succinogenes had be discovered in 
our lab. In this study, we investigated an E. coli strain 
over-expressing the gshF from A. succinogenes. Systematic 
metabolic engineering strategies were applied in E. coli to 
investigate their effects on GSH production, including 
the reduction of l-cysteine degradation, manipulation of 
the glucose storage pathway, and elimination of the bio-
logical degradation of GSH (Fig. 1). The performances of 
the engineered E. coli strains were investigated and com-
pared with the original strain in fed-batch cultivation in 
a 5-l bioreactor. Because the deletion of genes can affect 
protein expression, the proteomes of wild type MG1655 
and its mutant with a penta-gene deletion were also 
investigated.
Results and discussion
Effect of tnaA knockout on l‑cysteine degradation
GSH is synthesized from three amino acids (l-glutamate, 
glycine and l-cysteine). Among them, l-cysteine is the 
most expensive and accounts for the major cost in GSH 
production. Reducing l-cysteine degradation in E. coli is 
beneficial for increasing the availability of l-cysteine for 
GSH synthesis. The cysteine desulfhydrase (CD) cata-
lyzes the degradation of l-cysteine, and two cysteine 
desulfhydrases, tryptophanase encoded by tnaA and 
cystathionine β-lyase encoded by metC), are mainly 
responsible for the l-cysteine degradation in E. coli [19]. 
The key degradation gene tnaA was first interrupted in 
E. coli MG1655 to obtain the mutant strain MG001, and 
the l-cysteine degradation ability was compared with the 
wild type strain (Fig.  2). When MG001 was incubated 
with 80  mg/L l-cysteine for 2  h, the residual amount 
of l-cysteine was 65.76 ±  1.95  mg/L (82.2 ±  0.02  % of 
the initial amount). In contrast, the residual l-cysteine 
dropped to 16.54 ±  2.55  mg/L for the wild type strain. 
Thus, the amount of l-cysteine degraded by the wild 
type strain was 4.46-fold higher than that degraded by 
MG001. The result showed that the disruption of tnaA 
Page 3 of 12Zhang et al. Microb Cell Fact  (2016) 15:38 
significantly reduced the degradation of l-cysteine as 
expected. However, the degradation of l-cysteine was 
not eliminated completely due to the activities of other 
cysteine desulfhydrases in E. coli, such as cystathionine 
β-lyase (CBL, encoded by metC). The other additional 
proteins including O-acetylserine sulfhydrylase-A, 
O-acetylserine sulfhydrylase-B, and MalY were also iden-
tified to have l-cysteine desulfhydrase activity [22].
Effect of the interruption of ggt and pepT on GSH 
degradation
Previous studies have indicated that GSH is signifi-
cantly degraded close to the end of the fermentation 
process, resulting in a lower GSH production level. 
The key enzymes related to GSH degradation include 
γ-glutamyltranspeptidase encoded by ggt and tripepti-
dase encoded by pepT; and the inactivation of GGT and 
PepT activities can effectively reduce the degradation of 
GSH in E. coli [17]. The GGT deletion strategy was also 
adopted in an S. cerevisiae strain over-expressing GCS 
and GS, resulting in a 1.7-fold increase in GSH accu-
mulation [15]. Single ggt or pepT deletion and a double 
deletion were conducted, obtaining the mutants MG003, 
MG004 and MG034, respectively. To investigate the 
effect of the deletion of these genes on the degradation 
of GSH, E. coli MG1655 and its mutants were incu-
bated with 10 mM GSH at 37  °C for 2 h; the results are 
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Fig. 1 Metabolic pathways of Escherichia coli for GSH production, including the pathways related to central carbon metabolism, precursor amino 
acid production, and GSH degradation. glgB glycogen-branching enzyme, serA D-3-phosphoglycerate dehydrogenase, cysE serine acyltransferase, 


























Fig. 2 The residual l-cysteine concentrations in the mutant and wild 
type strains after 2 h of incubation
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concentration of the residual GSH was 7.6 ± 0.14 mM in 
MG034 (Δggt, ΔpepT), which was 2.4-fold that of the con-
trol (E. coli MG1655). The residual GSH concentration in 
MG003 was also high (6.9 ±  0.20 mM), which was 2.1-
fold that of in E. coli MG1655. These results suggested 
that GGT was the most important enzyme responsible 
for GSH degradation and that deletion of both ggt and 
pepT could significantly suppress the GSH degradation.
Manipulation of the energy supply
GSH synthesis is an energy intensive process because 
the formation of 1  mol of GSH requires 2  mol of ATP. 
However, the efficiency of the ATP supply or utilization 
for GSH production seems to be very low because only 
0.5 % of the total ATP regenerated in the glycolytic path-
way is used for GSH production under anaerobic condi-
tions [13]. To improve GSH productivity, we attempted 
to direct the flux of glucose to the glycolytic pathway 
to benefit ATP regeneration by inactivating the glyco-
gen generation pathway. The biosynthesis of glycogen 
from glucose is catalyzed by three enzymes: glycogenin 
glucosyltransferases, glycogen synthase, and glycogen-
branching enzyme (GBE). This pathway is controlled by 
GBE [23–25]. Yoshida et al. reported that an engineered 
S. cerevisiae in which the ATP consuming glucose-glyco-
gen bypass pathway had been shut-down by deletion of 
the GBE achieved 3.1-fold higher ATP-generating activity 
and 1.7-fold higher GSH productivity compared with the 
control strain [15]. In this work deletion of glgB encoding 
GBE was expected to shut down glycogen accumulation. 
Therefore, the mutant strain MG005 was constructed by 
interrupting the glgB gene in E. coli MG1655. To deter-
mine whether this mutation affected the intracellular 
ATP content, the ATP pool was quantified and compared 
to MG1655 cultured in M9 medium (Fig.  4). The ATP 
content in MG005 was 16–18  % higher compared to 
the control, which was in agreement with the previous 
study [15]. The results confirmed that the deletion of glgB 
effectively reduced ATP and carbon consumption for gly-
cogen accumulation.
ATP is an important cofactor of GSH production. Yeast 
was applied to GSH production to take advantage of its 
strong ability for ATP regeneration through the EMP 
pathway [13]. A coupled system composed of recombi-
nant E. coli and S. cerevisiae was also used to produce 
GSH [14]; however, the efficiency of ATP utilization was 
still low compared to the single yeast system. Because the 
transfer of ATP formed in S. cerevisiae to recombinant 
E. coli is difficult, the cooperation between ATP genera-
tion and glutathione synthesis seemed to be inefficient. 
Murata et  al. reported that the low GSH production of 
permeated cells immobilized using a polyacrylamide gel 
was caused by the low efficiency of the ATP supply: only 
0.5  % of the total regenerated ATP from the glycolytic 
pathway was actually used for GSH synthesis in E. coli 
[13]. Shutting-down the glucose-glycogen bypass path-
way resulted in more glucose being driven into the glyco-
lytic pathway to generate more ATP.
The irreversible transformation of adenosine to hypox-
anthine is another reason for the low efficiency of ATP 
regeneration in GSH biosynthesis [26]. A strain with an 
add (encoding adenosine deaminase) mutation showed 
enhanced GSH production. However, Hara et  al. [27] 
found that the deletion of add resulted in a reduced cell 
density due to the down-regulated tricarboxylic acid 
cycle. In the present study, deletion of add in MG1655 
resulted in little increase in the intracellular ATP level 
(data not shown). Hara et  al. [27] also reported that 34 
out of 40 mutated genes which were related to ATP gen-
eration resulted in higher glutathione production. There-
fore, it can be expected that screening more appropriate 
target genes can effectively increase the ATP generation 























Fig. 3 The residual GSH concentrations in the mutants and wild type 


























Fig. 4 Effect of the glgB knockout on the concentration of intracel-
lular ATP in E. coli during cultivation
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Production of GSH by the whole‑cell biocatalyst
Serine is the common precursor of l-cysteine and gly-
cine and is derived from 3-phosphoglycerate (Fig.  1). 
Hence, the supply of serine is critical for the availability 
of both precursors. In E. coli, l-serine is deaminated by 
three very specific high-Km l-serine deaminases (L-SDs): 
SdaA, SdaB and TdcG [28–30]. SdaA was reported to be 
the gene encoding either the structural gene of L-SD that 
catalyzes the deamination of serine to pyruvate or a posi-
tive activator of transcription [31]. To enhance the fluxes 
to l-cysteine and glycine, we knocked out sdaA to con-
struct the double mutant MG012 by deletion of sdaA in 
the tnaA mutant MG001. As mentioned above, the ggt 
of MG012 was deleted to form MG123 and pepT was 
deleted in MG123 to obtain MG1234. Finally, the strain 
MG12345 was constructed by deleting glgB (Table  1). 
Overexpression of the bifunctional l-glutathione syn-
thetase GshF from S. thermophilus was reported to sig-
nificantly enhance glutathione synthesis [12]. In this 
study, the newly discovered gshF of A. succinogenes was 
over-expressed in the various mutants and MG1655 by 
transforming them with the plasmid pTrc99a-as carrying 
gshF as (Table 1). The GshF was successfully expressed in 
the mutant strains, however, the expression levels in the 
mutant strains were lower than those in the control strain 
ZJ000 (Fig. 5). The overexpression level of the recombi-
nant protein, GshF, seem to be affected by the deletion of 
these genes of the host strain.
To elucidate the capability of GSH biosynthesis in these 
strains, resting cells were used for GSH synthesis. The 
concentrations and yields of GSH based on l-cysteine 
for these engineered strains are shown in Fig. 6. Deletion 
of tnaA and sdaA (ZJ012) resulted in 13.10 and 16.70 % 
increases in the GSH concentration and yield compared 
with ZJ000, respectively. These improvements were 
caused by the enhanced supply of precursors for GSH 
biosynthesis. The production and yield of GSH were 
increased in ZJ123 and ZJ1234 due to the decreased deg-
radation of GSH. ZJ1234 produced the highest concen-
tration (16.20 ± 0.45 mM) and yield (0.81 ± 0.02 mmol/
mmol) of GSH, which were 50.97 and 27.35  % higher 
than those for ZJ000, respectively. During the experi-
ments, the GSH produced by ZJ123, ZJ1234, and ZJ12345 
did not decrease significantly, indicating that the lack of 
ggt and pepT prevented GSH degradation and further 
increased the yield. Because the whole-cell biocatalyst 
required the addition of ATP, we were not able to observe 
the effect of the glgB deletion on GSH synthesis. Hence, 
Table 1 Strains and plasmids
Name Characteristic Source
Strain
 MG1655 Wild type of Escherichia coli Laboratory collection
 MG001 MG1655 ΔtnaA::KanR This work
 MG003 MG1655 Δggt::KanR This work
 MG004 MG1655 ΔpepT::KanR This work
 MG005 MG1655 ΔglgB:: KanR
 MG012 MG1655 ΔtnaAΔsdaA::KanR This work
 MG034 MG1655 ΔggtΔpepT::KanR This work
 MG123 MG1655 ΔtnaAΔsdaAΔggt::KanR This work
 MG1234 MG1655 ΔtnaAΔsdaAΔggtΔpepT::KanR This work
 MG12345 MG1655 ΔtnaAΔsdaAΔggtΔpepTΔglgB::KanR This work
 ZJ000 MG1655 harboring pTrc99a-as This work
 ZJ001 MG001 harboring pTrc99a-as This work
 ZJ012 MG012 harboring pTrc99a-as This work
 ZJ123 MG123 harboring pTrc99a-as This work
 ZJ1234 MG1234 harboring pTrc99a-as This work
 ZJ12345 MG12345 harboring pTrc99a-as This work
Plasmid
 pKD4 kan cassette template, KanR [32]
 pKD46 λ Red recombinase under arabinose-inducible araBAD promoter, temperature-conditional  
replicon, AmpR
[32]
 pCP20 FLP recombinase expression, temperature-conditional replicon, AmpR and CmR [32]
 pET28a-as pET28a carries a bifunctional glutathione synthetase (gshF) from Actinobacillus succinogenes, KanR Yang et al. (to be published)
 pTrc99a Cloning vector, AmpR Laboratory collection
 pTrc99a-as pTrc99a carries a bifunctional glutathione synthetase (gshF) from Actinobacillus succinogenes, AmpR This work
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we investigated fed-batch fermentation using glucose as 
the sole carbon and energy source.
Comparative proteomic analysis of MG12345 and MG1655
Although soluble GshF was expressed in all of the con-
structed mutant strains, the expression levels showed 
significant differences among these mutants following 
induction with the same IPTG concentration (Fig. 5). The 
deletion of genes can affect protein synthesis. Therefore, 
it would be useful to gain a global understanding of the 
differences in gene expression between the wild type and 
mutant strains.
To identify the major changes in gene expression 
responsible for the differences in gshF expression, we 
performed a proteomic study using 2-DE that compared 
the protein levels in MG12345 with MG1655. As shown 
in Table  2, 22 proteins that demonstrated significantly 
different expression levels were identified by mass spec-
trometry coupled with genome-wide analysis of E. coli. 
Most of the proteins were involved in central metabolism 
and amino acid metabolic processes. Pyruvate kinase 
(encoding by pykF) catalyzes phosphoenolpyruvic acid 
(PEP) to form pyruvate and is a rate-limiting enzyme in 
the glycolysis pathway. The reduced expression of pykF 
in MG12345 led to an increase in the intracellular con-
centration of PEP and also caused an increase in the con-
centrations of G6P and F6P, which in turn decreased the 
glucose uptake rate. The increased PEP also inhibited 
phosphofructose kinase (encoding by pfk) activity, which 
was responsible for the decreased glycolytic flux and 
the down regulation of the glycolytic activities [33]. The 
expression level of pyruvate dehydrogenase (encoding by 
aceE), which catalyzes the reaction from pyruvate to the 
formation of acetyl-CoA, was only 0.13-fold in MG12345; 
this decrease resulted in reduced TCA cycle flux, leading 
to a decrease in precursors and energy for protein syn-
thesis. Some membrane proteins, such as glutamine syn-
thetase (encoding by glnA) and periplasmic putrescine 
binding protein (encoding by potE), are related to the 
transport of amino acids and can also affect the expres-
sion of proteins. Therefore, the differences in these pro-
teins could explain the reduced expression of GshF in the 
mutant ZJ12345 compared to the wild type strain and 
help explain why the mutant required a higher IPTG con-
centration to obtain GshF activity similar to the wild type 
host strain.
Production of GSH in fed‑batch fermentation
ZJ1234 and ZJ12345 were selected to produce GSH in a 
fed-batch culture using ZJ000 as the control strain. The 
inducer concentration was different for the three strains 
because the expression of GshF in ZJ1234 and ZJ12345 
was lower than that in ZJ000 under the same induction 
conditions (Fig. 5). The GshF activities were similar for all 
three strains when the IPTG concentration was 0.5 mM 
for ZJ1234 and ZJ12345 and 0.05  mM for ZJ000. The 
results of the fed-batch cultures are shown in Fig. 7. The 
synthesis of GSH in all of these strains increased rapidly 
after the addition of the precursor amino acids (Fig.  7). 








Fig. 5 Expression of the GSH synthase GshF in different hosts with 
different genetic backgrounds. The concentration of IPTG was 0.5 mM 

















































Fig. 6 The production of GSH by whole-cell biocatalyst in the engi-
neered strains using ZJ000 as the control. a The concentration of GSH 
during the process; b the highest yield of GSH
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The final concentrations of GSH for ZJ1234 and ZJ12345 
reached 17.74  mM (5.45  g/L) and 19.10  mM (5.87  g/L), 
respectively, compared with 14.32  mM (4.40  g/L) for 
ZJ000 (Fig. 7). The yields based on the added l-cysteine 
were 0.71 and 0.76 mmol/mmol for ZJ1234 and ZJ12345, 
which were 13.68 and 18.73 % higher than that for ZJ000, 
respectively. The GSH concentration rapidly decreased 
at the end of the fed-batch culture of ZJ000, while no 
GSH degradation occurred for ZJ1234 and ZJ12345. 
These results were due to the deletion of ggt and pepT, 
which decreased the degradation of GSH; moreover, the 
GSH production by ZJ12345 was 7.71 % higher than that 
by ZJ1234. In contrast to the experiments using resting 
cells where ATP was added into the reaction system, the 
higher GSH production and yield in the fed-batch cul-
tures of ZJ124345 compared to ZJ1234 indicated that the 
deletion of glgB led to an improved ATP supply ability.
Conclusions
In conclusion, the production of GSH in E. coli was 
improved by the modification of metabolic path-
ways, including the reduction of l-cysteine degrada-
tion, manipulation of the glucose storage pathway, and 
elimination of the biological degradation of GSH. Dele-
tion of the precursor degradation genes reduced the deg-
radation significantly and the production of GSH in the 
mutant which overexpressed gshF from A. succinogenes 
increased by 13.10 %. The deletion of ggt and pept further 
increased the production of GSH, and the yield reached 
to 0.81  mmol/mmol, which is 27.35  % higher than that 
for ZJ000. In the end, the glgb encoding the glycogen-
branching enzyme was disrupted for a higher energy 
supplement. The penta-mutant ZJ12345 was constructed 
successfully, and the production of GSH was 19.10 mM in 
fed-batch fermentation, which was 1.33-fold the produc-
tion of MG1655 expressing the same gene. This improve-
ment of production should help industrial glutathione 
production because of the higher yield and reduced deg-
radation of product.
Methods
Strains, plasmids and molecular biology methods
All the strains and plasmids used in this study are listed 
in Table 1. The wild type E. coli strain MG1655 was used 
as the starting strain to implement metabolic engineer-
ing. Gene knockout was performed using the one-step 
Table 2 Mass spectrometry (MS) analysis of  differentially expressed proteins between  E. coli MG1655 and  MG12345 









1 I16 acpH Acyl carrier protein phosphodiesterase 22,937 5.53 46 37.05
2 I17 aroC Chorismate synthase 38,520 5.61 23 20.71
3 I18 pyrC Dihydroorotase 38,983 5.68 41 14.7
4 I19 glnA Glutamine synthetase, type I 51,230 5.27 44 0.14
5 I22 aldA Lactaldehyde dehydrogenase 52,362 5.07 30 0.25
6 I23 potD Spermidine/putrescine ABC transporter substrate-
binding protein
40,899 5.66 11 69.67
7 I24 cpdB 2′,3′-cyclic-nucleotide 2′-phosphodiesterase 70,799 5.52 21 0.17
8 J1 dppA Periplasmic dipeptide transport protein 60,483 6.36 28 0.11
9 J2 aceE Pyruvate dehydrogenase 62,256 5.86 26 7.39
10 J3 gadA Glutamate decarboxylase alpha 55,736 5.37 26 7.01
11 J5 talB Transaldolase 35,838 5.75 31 15.65
12 J6 dapD 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyl-
transferase
30,045 5.56 47 0.023
13 J8 menB Naphthoate synthase 32,737 6.32 25 57.61
14 J9 glmM Phosphoglucosamine mutase 47,830 5.61 25 32.56
15 J10 mrp Mrp protein 41,222 6.05 19 10.05
16 J11 glpQ Periplasmic Glycerophosphodiester Phosphodiesterase 40,617 5.35 32 0.156
17 J12 potE Periplasmic putrescine binding protein 40,900 5.67 18 0.09
18 J13 aph Aminoglycoside 3′-phosphotransferase 29,315 4.64 62 9.45
19 J15 pykF Pyruvate kinase I 50,675 5.77 26 5.86
20 J16 aspA Aspartate ammonia-lyase 52,920 5.25 12 0.055
21 J17 tnaA Tryptophanase 53,081 6 21 12.36
22 J19 oppA Periplasmic oligopeptide-binding protein 46,735 5.5 39 0.02
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Culture time (h) 
Fig. 7 Profiles of fed-batch fermentation by E. coli strains ZJ000 (a), ZJ1234 (b) and ZJ12345 (c). (filled square) DCW; (filled triangle) GSH; (filled star) 
Glucose; (filled circle) Acetic acid
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inactivation method of Datsenko and Wanner [32]. The 
primers for PCR are listed in Table 3. The gene deleted in 
a mutant was marked with a number in the name of the 
constructed strain (Table 1). To create the tnaA mutant, 
the DNA fragment containing the kanamycin resistance 
cassette for homologous recombination was amplified 
by PCR using the primers F-tnaA-FRT and R-tnaA-FRT 
and the plasmid pKD4 as the template. The insertion 
was confirmed by PCR using the primers F-tnaA-check 
and R-tnaA-check listed in Table 3. Deletion of the genes 
sdaA, ggt, pepT and glgB was performed similarly.
To construct the plasmid for gshF expression, the 
gshF of A. succinogenes was amplified through PCR 
using pET28a-as as the template. The PCR product was 
digested with SacI and PstI and then inserted into the 
sites of pTrc99a digested with the same enzymes to form 
the plasmid pTrc99a-as.
Medium
Luria–Bertani (LB) medium containing 10 g/L tryptone, 
5  g/L yeast extract, and 10  g/L NaCl was used to culti-
vate the E. coli strains during strain construction. M9 
minimal salt medium containing 5 g/L glucose, 15.1 g/L 
Na2HPO4, 3  g/L KH2PO4, 0.5  g/L NaCl, 1  g/L NH4Cl, 
0.5 g/L MgSO4·7H2O, 0.01 g/L CaCl2, 0.2 mL/L 1 % vita-
min B1 and a 0.05 mL/L stock solution of trace elements 
was used for the cultivation of engineered E. coli strains 
in different experiments for GSH production. The stock 
solution of trace elements contained the following in 
3 M HCl: FeSO4·7H2O 80, AlCl3·6H2O 10, ZnSO4·7H2O 
2.0, CuCl2·2H2O 1.0, NaMoO4·2H2O 2.0, MnSO4·nH2O 
10, CoCl2 4.0, and H3BO4 0.5  g/L. An appropriate anti-
biotic (50 mg/L kanamycin or 100 mg/L ampicillin) was 
included in the medium when needed. For the induc-
tion of gene expression, 0.05–0.5  mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added as indicated in 
different experiments.
For the fed-batch culture in the 5-l bioreactor, medium 
containing 15  g/L Na2HPO4·12H2O, 3  g/L KH2PO4, 
0.5  g/L NaCl, 3  g/L NH4Cl, 0.2  g/L MgSO4∙7H2O, 
0.011 g/L CaCl2, 0.5 mL/L vitamin B1 (1 % w/v), 0.5 mL/L 
of a stock solution of trace elements, and 4 g/L glucose 
was used. The feeding medium contained 500 g/L glucose 
and 25 g/L MgSO4·7H2O.
Culture conditions
The primary pre-culture was prepared by transfer of 
100 μL of the stock culture to 3 mL of LB medium. The 
cells were aerobically incubated at 37  °C and 220  rpm 
overnight. Then, 1 mL of the overnight culture was trans-
ferred into 50 mL of LB or M9 medium in 250 mL flasks 
for further cultivation (kanamycin or ampicillin was 
added when needed). An appropriate concentration of 
IPTG was added when the cell density reached the OD600 
value of 0.4–0.6; the induction time was 2–6 h for the dif-
ferent engineered strains.
To investigate the effect of gene knockout on l-cysteine 
and GSH degradation, the engineered strains were cul-
tured in the flasks as described above and the cells were 
collected by centrifugation (6000  rpm, 4  °C for 5  min) 
after two washes with 50 mM phosphate buffer (pH7.0). 
Then, the cells were resuspended in 0.2  M phosphate 
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buffer (pH7.0) containing different concentrations of 
l-cysteine or GSH and 0.5 % (v/v) toluene, and the reac-
tion mixture was incubated at 37 °C for 2 h. Samples were 
collected for the determination of the residual l-cysteine 
and GSH concentrations.
The fed-batch culture was performed in a 5-L bioreac-
tor (NC-Bio, Shanghai, China) with the initial working 
volume of 2.5 L. The primary inoculum was prepared 
by transferring 1  mL of the stock culture to 30  mL of 
LB medium in a 250 mL flask and culturing at 37 °C for 
6  h. The primary inoculum (1  mL) was transferred into 
140 mL of fresh LB medium in a 500 mL flask and cul-
tured for 8  h to obtain the secondary inoculum, which 
was inoculated directly into the bioreactor. The feeding 
medium was continuously added into the bioreactor to 
obtain a constant specific growth rate (0.25 ± 0.02 h−1) 
after the initial glucose in the medium was completely 
consumed. IPTG was added into the bioreactor when 
the concentration of the biomass reached approximately 
4.5 g DCW/L. After 2.5 h of induction, l-glutamate, gly-
cine and l-cysteine were added into the bioreactor to 
concentrations of 25 mM. Before adding the precursors, 
the pH was maintained at 7.0 by automatic addition of 
25 % ammonia; however, 4 M KOH was used during the 
GSH synthesis phase. The temperature of the fed-batch 
culture was maintained at 37 °C.
Whole‑cell biocatalyst
The GshF-overexpressing cells were obtained by cen-
trifugation of the induced culture at 12,000 rpm and 4 °C 
for 5  min, followed by two washes with 50  mM phos-
phate buffer (pH 7.0). The cells were stored at −20  °C 
for the experiment as a catalyst. GSH synthesis using 
the whole-cell biocatalyst was performed in 0.2 M phos-
phate buffer (pH 7.0) containing 40  mM l-glutamate, 
20  mM  l-cysteine, 40  mM glycine, 20  mM MgCl2 and 
20 mM ATP. A total of 1 g (wet weight) of cells was added 
to the 10 mL reaction mixture, and the reaction was per-
formed at 37 °C and 220 rpm.
Two‑dimensional electrophoresis (2‑DE)
The 2-DE was performed as described by O’Farrell [34] 
with some modifications. The E. coli cells (100 mL) were 
collected (6000  rpm, 4  °C, 10  min) and resuspended 
in 5  mL of lysis buffer containing 8  M urea, 4  % (w/v) 
CHAPS, and 1 % (w/v) DTT and sonicated on ice for 90 
cycles (a working period of 3 s in a 6 s interval for each 
cycle) at a power output of 200 W by an ultrasonic dis-
ruptor (JY92-II, Scientz Biotechnology Co., Ningbo, 
China). The clear cell lysate was collected and the pro-
teins in the supernatant were precipitated by treating 
with 10  % (v/v) trichloroacetic acid (TCA) on ice for 
30 min. The precipitate was collected (6000 rpm, 30 min, 
4  °C) and washed with 1  mL of acetone three times to 
remove the TCA. Finally, the proteins were dissolved in 
the same lysis buffer as described above. The concentra-
tion of soluble proteins was measured using the Coomas-
sie Brilliant Blue method [35]. The first dimension was 
run essentially as described in the Amersham Biosciences 
manual for 2D methods [36] with some modifications. 
Briefly, 1 mg of protein was added on the IPG strip (pH 
4–7, 24  cm), and the pre-programmed power supply 
(EPS 3500×l, Amersham Pharmacia Biotech) was started 
immediately. The voltage was changed over a linear gra-
dient from 30 to 1000 V over 4 h, followed by being held 
at 1000 V for 1 h; then, the voltage was increased linearly 
to 8000 V over 3 h and held at 8000 V for 10 h at 20 °C.
After completion of the isoelectric focusing, the strip 
was equilibrated in the equilibration solution as described 
by Barraclough [37] and placed on a polyacrylamide gel 
for SDS-PAGE with a Protean II unit (Bio-Rad, USA) at 
a constant voltage (300 V). After electrophoresis, the gel 
was stained with a staining solution [0.1  % coomassie 
brilliant blue (CBB) R250, 45 % methanol, and 10 % acetic 
acid] for 2 h. Then, the gel was transferred to the decol-
orant for 2 h. The CBB-stained gel was digitally imaged 
(GelDoc, Bio-Rad, USA) under UV excitation, and the 
image was analyzed with the software PDQuest 2D Elite. 
The experiment was repeated three times. Protein spots 
with significant differences in the knock-out strain were 
selected and identified using MS at Bo Yuan Bio-Tech, 
Shanghai, China.
Analytical methods
The cell density was estimated by measuring the opti-
cal density of an appropriately diluted culture sample at 
600  nm (OD600) using a UV-7504 Spectrophotometer 
(Xinmao Instrument, Shanghai, China). The culture was 
diluted to the linear range. Dry cell weight (DCW, g/L) 
was calculated from the optical density according to a 
linear relationship between OD600 and DCW. 50 mL cul-
ture sample was harvested at 4  °C and 12,000  rpm for 
10 min. The cell pellet was washed twice with deionized 
water, and dried at 85  °C to constant weight [38]. The 
optical density was converted to DCW based on a stand-
ard carve (1 OD600 = 0.41 g DCW/L). The concentration 
of l-cysteine was determined by the colorimetric method 
described by Gaitonde [39] using the reaction with nin-
hydrin. The ATP concentration was measured using high 
performance liquid chromatography (HPLC) [40]. Pro-
teins in the samples were precipitated by boiling or treat-
ing with 10 % cold perchloric acid and then centrifuging 
at 4 °C and 12,000 rpm for 10 min. The supernatant was 
used for analysis. GSH was measured by HPLC (LC-
10AT, Shimadzu, Japan) using a WondalSil C18 column 
(GL Sciences Inc., Japan) and a UV detector (SPD-20A, 
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Shimadzu, Japan) at 210  nm. The column temperature 
was 30  °C, and the mobile phase was a mixture of A 
[50  mM phosphate buffer (pH 3.0) containing 10  mM 
sodium 1-heptanesulfonate] and B (methanol) with an 
A/B ratio of 95/5 at a flow rate of 1  mL/min. The con-
centrations of glucose and acetic acid were monitored 
by HPLC (LC-10AT, Shimadzu, Japan) using an Amines 
HPX-87H column (Bio-Rad, USA) and a refractive index 
detector (RID-10A, Shimadzu, Japan). A mobile phase of 
2.5 mM H2SO4 at a 0.5 mL/min flow rate was used, and 
the column was operated at 55 °C [41].
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